May 2024 Newsletter

May 2024 Newsletter

New Animal Models


Press Release

Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies

Biocytogen’s Antibody Partner Syncromune? Inc. Presents Positive Results from SYNC-T? SV-102 Phase-1 Trial at AACR Annual Meeting 2024

Upcoming Events

ASGCT 2024

Date: May 7-11, 2024

Location: Baltimore, MD

Booth: #2388

Join us at booth #2388 if you are also attending ASGCT 2024 in Baltimore, MD from May 7-11, 2024! Explore our 100% guaranteed service and learn how our humanized models, disease models, and pharmacology services can enhance your Cell and Gene Therapy!?

PEGS Boston 2024

Date: May 13-17, 2024

Location: Boston, MA

Booth: #23

Poster: Generation of a Fully Human Antibody Library and Novel Linker/Payload to Facilitate Development of Antibody-Drug Conjugates and Other Antibody-Based Therapeutics

Poster number:?C017

Date: Thursday, May 16th

Oligonucleotide and Peptide Therapeutics USA

Date: May 13-17, 2024

Location: Boston, MA

Booth: Booth #10

ATS 2024

Date: May 17-22, 2024

Location: San Diego, CA

Booth: #734

要查看或添加评论,请登录

Biocytogen的更多文章

社区洞察

其他会员也浏览了